EUVIMEDEUVIMED entdecken
Crossref

Covalent remodeling of CRBN creates a non-canonical neosubstrate interface with NTAQ1

Andres H de la Peña, Justin T Cruite, Jianwei Che, Mary E Matyskiela, Philip P Chamberlain, Eric S Fischer, Lyn H Jones

Structure · 2026-11

DOI: 10.1016/j.str.2026.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2026-11. Verfasst von Andres H de la Peña und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neomorph Inc., San Diego, CA 92121, USA. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular glue degrader EM12-FS covalently modifies cereblon (CRBN) His353, enabling selective recruitment of the neosubstrate NTAQ1 to the CRL4CRBN ubiquitin ligase. We determined the cryo-EM structure of the NTAQ1-EM12-FS-CRBN-DDB1 complex, revealing a non-canonical neosubstrate interface created by covalent engagement of the CRBN sensor loop. Imidazylation repositions His353 to eliminate the steric clash that prevents NTAQ1 engagement by reversible IMiDs, and the engineered interface is stabilized by a distinctive T-shaped C-H/π interaction between sulfated His353 and NTAQ1 Phe126. Biochemical and mutational analyses define the determinants of ternary complex formation and ubiquitination. These findings show that site-specific synthetic modification of CRBN can reprogram induced-proximity pharmacology, expanding specificity beyond the G-loop degron and establishing a framework for covalent engineering of new degrader modalities.

Schlagwörter

Stichwörter der Autor:innen

CRBNNTAQ1covalent chemical probecryo-EMmolecular gluenon-canonical degronsulfonyl exchange

Autor:innen und Institutionen

  • Neomorph Inc., San Diego, CA 92121, USA.
  • Center for Protein Degradation, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA.
  • Center for Protein Degradation, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Bio…
  • Center for Protein Degradation, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA. Electronic address: lyn_…

Zitieren

APA

de la Peña, A. H., Cruite, J. T., Che, J., Matyskiela, M. E., Chamberlain, P. P., Fischer, E. S., & Jones, L. H. (2026). Covalent remodeling of CRBN creates a non-canonical neosubstrate interface with NTAQ1. Structure. https://doi.org/10.1016/j.str.2026.10.007

Vancouver

de la Peña AH, Cruite JT, Che J, Matyskiela ME, Chamberlain PP, Fischer ES, et al. Covalent remodeling of CRBN creates a non-canonical neosubstrate interface with NTAQ1. Structure. 2026. doi:10.1016/j.str.2026.10.007

BibTeX
@article{delaPea2026,
  author = {de la Peña, Andres H and Cruite, Justin T and Che, Jianwei and Matyskiela, Mary E and Chamberlain, Philip P and Fischer, Eric S and Jones, Lyn H},
  title = {Covalent remodeling of CRBN creates a non-canonical neosubstrate interface with NTAQ1},
  journal = {Structure},
  year = {2026},
  doi = {10.1016/j.str.2026.10.007}
}
Kostenlos starten →